2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.
Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide and in Taiwan. It is highly prevalent and has a tremendous impact on global health. Therefore, the Taiwan Society of Cardiology developed these best-evidence preventive guidelines for decision-making in clinical practice involving aspects of primordial prevention including national policies, promotion of health education, primary prevention of clinical risk factors, and management and control of clinical risk factors. These guidelines cover the full spectrum of ASCVD, including chronic coronary syndrome, acute coronary syndrome, cerebrovascular disease, peripheral artery disease, and aortic aneurysm. In order to enhance medical education and health promotion not only for physicians but also for the general public, we propose a slogan <b>(2H2L)</b> for the primary prevention of ASCVD on the basis of the essential role of healthy dietary pattern and lifestyles: "<b>Healthy Diet and Healthy Lifestyles to Help Your Life and Save Your Lives</b>". We also propose an acronym of the modifiable risk factors/enhancers and relevant strategies to facilitate memory: " <b>ABC<sub>2</sub>D<sub>2</sub>EFG-I'M<sub>2</sub> ACE"</b>: Adiposity, Blood pressure, Cholesterol and Cigarette smoking, Diabetes mellitus and Dietary pattern, Exercise, Frailty, Gout/hyperuricemia, Inflammation/infection, Metabolic syndrome and Metabolic dysfunction-associated fatty liver disease, Atmosphere (environment), Chronic kidney disease, and Easy life (sleep well and no stress). Some imaging studies can be risk enhancers. Some risk factors/clinical conditions are deemed to be preventable, and healthy dietary pattern, physical activity, and body weight control remain the cornerstone of the preventive strategy.
Authors
- Wen‐Jone Chen (ORCID: https://orcid.org/0000-0002-2098-5922)
- Yen‐Hung Lin (ORCID: https://orcid.org/0000-0001-8153-1441)
- Wei‐Ting Chang (ORCID: https://orcid.org/0000-0001-9525-2144)
- Ta‐Chen Su (ORCID: https://orcid.org/0000-0001-7523-7166)
- Charles Jia‐Yin Hou (ORCID: https://orcid.org/0000-0001-6602-5532)
- Ya‐Wen Lu (ORCID: https://orcid.org/0009-0008-2780-8321)
- Po‐Wei Chen (ORCID: https://orcid.org/0000-0003-2300-0698)
- Pey‐Rong Chen (ORCID: https://orcid.org/0000-0002-2035-7088)
- Chih‐Cheng Wu (ORCID: https://orcid.org/0000-0002-9690-6573)
- Tzung‐Dau Wang (ORCID: https://orcid.org/0000-0002-7180-3607)
- Yih‐Jer Wu (ORCID: https://orcid.org/0000-0002-5146-9234)
- Pang‐Yen Liu
- Chao-Ping Wang (ORCID: https://orcid.org/0000-0002-7387-787X)
- Kuo‐Liong Chien (ORCID: https://orcid.org/0000-0003-4979-8351)
- Ke-Hsin Ting (ORCID: https://orcid.org/0000-0001-8880-1774)
- Tsung‐Hsien Lin (ORCID: https://orcid.org/0000-0002-7226-8730)
- Yen‐Wen Wu (ORCID: https://orcid.org/0000-0003-1520-1166)
- Chun-Hung Su (ORCID: https://orcid.org/0000-0003-4003-008X)
- Cheng‐I Cheng (ORCID: https://orcid.org/0000-0002-3134-2447)
- Yu-Chen Wang (ORCID: https://orcid.org/0000-0001-8414-9379)
- Po‐Hsun Huang (ORCID: https://orcid.org/0000-0003-1584-6749)
- Po‐Lin Lin (ORCID: https://orcid.org/0000-0002-5664-4193)
- Chao-Feng Lin
- Wei-Wen Lin
- Chern‐En Chiang
- Jyh-Ming Jimmy Juang
- Yu-Shien Ko
- Kwo‐Chang Ueng
- Wen-Han Pan
- Chih-Sheng Chu
- Hsien-Yuan Chang
- Hsueh-Wei Yen
- Hao-Min Cheng
- Hsing-Ban Leu
- Chin-Chou Huang
- Ting-Hsing Chao
Institutions
- Tri-Service General Hospital (TW)
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Medical University (TW)
- National Taiwan University (TW)
- Mackay Memorial Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Taichung Veterans General Hospital (TW)
- National Taiwan University Hospital (TW)
- National Defense Medical Center (TW)
- Yuan Ze University (TW)
Publication Details
- Journal
- PubMed
- Published
- 2024-09-01
- DOI
- https://doi.org/10.6515/acs.202409_40(5).20240724a
- Citations
- 6
- Primary Topic
- Cardiovascular Health and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 2.41
Funders
- National Science Council
- National Science and Technology Council